FindTrial
Sign In

A study to analyse the outcome of prostate cancer of the patients who have already received treatment

Retrospective Study of trends in the clinico - demographic characteristics, treatment decisions and clinical outcomes of Prostate cancer patients registered at Tata Memorial Hospital. (ReSTCaP) - ReSTCaP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/08/027201
Enrollment
3600
Registered
2020-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C61- Malignant neoplasm of prostate

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: All patients registered at TMH during January 2013 through December 2019 and diagnosed to have CaP as the primary or second malignancy.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
trend of clinico-demographic characteristics in CaP patientsTimepoint: 6 years (2013-2019)—

Secondary

MeasureTime frame
To compare the duration of relapse free survival among CaP patientsTimepoint: registered during January 2013 - December 2019;To study the association of demographic characteristics with stageTimepoint: At presentation of Prostate cancer;To study the trend in treatment modalities offered at various stages of prostate cancer.Timepoint: registered during January 2013 - December 2019 ;To study treatment compliance of these patients and its trend.Timepoint: registered during January 2013 - December 2019—

Countries

India

Contacts

Public ContactDr Ganesh Bakshi

Tata Memorial Centre

gkbakshi1973@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026